On this page
Margenza
margetuximab-cmkb
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Margenza
Proper name
margetuximab-cmkb
Licence type
351(a)
BLA number
761150
Applicant
MacroGenics Inc.
Center
CDER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 250MG/10ML (25MG/ML) | Injection | Intravenous | Single-Dose Vial | Rx | December 16, 2020 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |